Your session is about to expire
← Back to Search
Behavioural Intervention
K-Talk Intervention for HPV Vaccination
N/A
Recruiting
Led By Minjin Kim, PhD., RN
Research Sponsored by University of Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline, 3-month, 6-month, and 12-month follow-up
Awards & highlights
Study Summary
This trial will test if an AI chatbot + storytelling intervention can help Korean Americans aged 18-26 get vaccinated for HPV.
Who is the study for?
This trial is for Korean Americans aged 18 to 26 who live in the U.S., speak or read English, have not received an HPV vaccine, and use a mobile device. It's designed to see if a video and chatbot program can increase HPV vaccination rates.Check my eligibility
What is being tested?
The study tests K-Talk, which combines storytelling videos and AI chatbot technology to encourage HPV vaccinations. Participants are split into four groups: one with both chatbot and storytelling, one with just the chatbot, one with only storytelling, and one receiving written information.See study design
What are the potential side effects?
Since this trial focuses on educational interventions rather than medical treatments or drugs, there are no direct side effects from the interventions being tested.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at baseline, 3-month, 6-month, and 12-month follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline, 3-month, 6-month, and 12-month follow-up
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of participants who completed 3 doses of HPV vaccines at 12-months
Number of participants who completed 3 doses of HPV vaccines at 6-months
Number of participants who received at least one dose of HPV vaccine at 12-month
+2 moreSecondary outcome measures
Assessing Perceived Risk of HPV and Other STIs: A 17-Item Survey (on a 1-5 Likert scale)
Assessment of Intention to Receive HPV Vaccine: Two Items Self-Report
Assessment of Knowledge about HPV and HPV Vaccines: A 34-Item Survey (True/False/I don't know)
Trial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: Storytelling InterventionExperimental Treatment2 Interventions
After completing the pre-test survey, participants from all intervention groups will receive the written information. Subsequently, they will be randomly assigned to one of the intervention groups. The storytelling intervention group will only be exposed to periodic release of stories via email for 3 months.
Group II: K-Talk Intervention: Storytelling and AI ChatbotExperimental Treatment2 Interventions
After completing the pre-test survey, participants from all intervention groups will receive the written information. Subsequently, they will be randomly assigned to one of the intervention groups. The K-Talk group will receive a series of weekly storytelling videos, and access to the chatbot via the web-based platform KakaoTalk for 3 months.
Group III: K-Bot (AI Chatbot Intervention) InterventionExperimental Treatment2 Interventions
After completing the pre-test survey, participants from all intervention groups will receive the written information. Subsequently, they will be randomly assigned to one of the intervention groups. The K-Bot group will only interact with the chatbot via the web-based platform or KakaoTalk for 3 months.
Group IV: Written InformationActive Control1 Intervention
This group will only be exposed to written, didactic HPV education materials after the pre-test.
Find a Location
Who is running the clinical trial?
University of CincinnatiLead Sponsor
428 Previous Clinical Trials
634,234 Total Patients Enrolled
Minjin Kim, PhD., RNPrincipal InvestigatorUC College of Nursing
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am not between 18 and 26 years old.I am between 18 and 26 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Storytelling Intervention
- Group 2: K-Talk Intervention: Storytelling and AI Chatbot
- Group 3: K-Bot (AI Chatbot Intervention) Intervention
- Group 4: Written Information
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the current enrollment count for participants in this experiment?
"Affirmative. Information provided by clinicaltrials.gov reveals that this medical trial, initiated on May 10th 2023, is currently recruiting patients. One site will be enrolling 160 participants in total."
Answered by AI
Is there an available opportunity to partake in this experiment?
"Affirmative. The listing on clinicaltrials.gov confirms that this medical trial is still looking for patients to participate, with the initial post dating back to May 10th 2023 and last updated on May 31st 2023. 160 participants need to be enrolled from 1 location only."
Answered by AI
Is this trial accepting individuals over 45 years old?
"This trial seeks volunteers in the 18 to 26 age bracket. Additionally, there are 3 trials available for minors and 2 more designed with seniors in mind."
Answered by AI
Is there any way I can participate in this research endeavor?
"Eligibility criteria for this trial requires that participants have human papillomavirus and are between 18-26 years old. This study is accepting a total of 160 individuals."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger